# Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis

> **NCT02264301** · NA · UNKNOWN · sponsor: **Chengdu PLA General Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Puerarin injection 400 mg
- **DRUG:** Qingkailing injection 40 ml

## Key facts

- **NCT ID:** NCT02264301
- **Lead sponsor:** Chengdu PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264301, "Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02264301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*